{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-031564","form_type":"8-K12B","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2026-07-01T20:43:06+00:00","discovered_at":"2026-07-01T20:44:00.482947+00:00","generated_at":"2026-07-01T20:44:11.676864+00:00","sec_items":["1.01","3.01","8.01","3.03","5.01","5.02","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ChronoScale Corporation reorganizes into holding company structure, becomes ChronoScale Holdings Corporation","bullets":["On July 1, 2026, ChronoScale completed a holding company reorganization, merging with a subsidiary of newly formed ChronoScale Holdings.","Each outstanding share of ChronoScale common stock was automatically converted into one share of ChronoScale Holdings common stock.","ChronoScale Holdings became the successor issuer under Rule 12g-3(a) and will continue trading on Nasdaq under ticker CHRN.","Andrew Schaap was appointed to the Board of Directors on June 29, 2026.","ChronoScale contributed all equity of its subsidiary Applied Digital Cloud Corporation to ChronoScale Holdings."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-031564","json":"https://secwatch.observer/filing/0001493152-26-031564.json","markdown":"https://secwatch.observer/filing/0001493152-26-031564.md","text":"https://secwatch.observer/filing/0001493152-26-031564.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226031564/0001493152-26-031564-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226031564/form8-k12b.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T20:44:11.676864+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f842373f22","claim":"Andrew Schaap was appointed as Director at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"On June 29, 2026, Mr. Schaap was appointed to serve on the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226031564/0001493152-26-031564-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}